CSBR insider trading
NasdaqCM HealthcareCHAMPIONS ONCOLOGY, INC.: insider trade history from SEC Form 4 filings.
About CHAMPIONS ONCOLOGY, INC.
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Company website: www.championsoncology.com
CSBR insider activity at a glance
FilingIQ tracks 134 insider transactions for CSBR in filings since Mar 13, 2015. The most recent transaction is dated Oct 15, 2026.
Across the full history, 80 open-market purchases
and 6 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest CSBR Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for CSBR?
- FilingIQ tracks 134 Form 4 insider transactions for CSBR (CHAMPIONS ONCOLOGY, INC.), covering filings from Mar 13, 2015 onwards. 1 of those are dated within the last 90 days.
- Are CSBR insiders net buyers or net sellers?
- Across the full Form 4 history for CSBR, 80 transactions (60%) were open-market purchases and 6 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CSBR insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is CSBR in?
- CHAMPIONS ONCOLOGY, INC. (CSBR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $83.18M.
Methodology & sources
Every CSBR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.